AAAAAA

   
Results: 1-22 |
Results: 22
EFFECTS OF CARDIOTROPHIN-1 ON HEMODYNAMICS AND CARDIAC-FUNCTION IN CONSCIOUS RATS
Authors: JIN HK YANG RH KO A PENNICA D WOOD WI PAONI NF
Citation: Hk. Jin et al., EFFECTS OF CARDIOTROPHIN-1 ON HEMODYNAMICS AND CARDIAC-FUNCTION IN CONSCIOUS RATS, Cytokine, 10(1), 1998, pp. 19-25
GROWTH-HORMONE THERAPY MODIFIES MYOCYTE CALCIUM-DEPENDENT CONTRACTILERESERVE INDEPENDENT OF HYPERTROPHY IN POST-INFARCT FAILING HEARTS
Authors: TAJIMA M WEINBERG EO BARTUNEK J JIN HK YANG RH PAONI NF LORELL BH
Citation: M. Tajima et al., GROWTH-HORMONE THERAPY MODIFIES MYOCYTE CALCIUM-DEPENDENT CONTRACTILERESERVE INDEPENDENT OF HYPERTROPHY IN POST-INFARCT FAILING HEARTS, Circulation, 98(17), 1998, pp. 739-739
GAMMA-INTERFERON INHIBITS CARDIAC-HYPERTROPHY INDUCED BY PROSTAGLANDIN-F2-ALPHA
Authors: LU HW JIN HK YANG RH OGASAWARA AK PAONI NF
Citation: Hw. Lu et al., GAMMA-INTERFERON INHIBITS CARDIAC-HYPERTROPHY INDUCED BY PROSTAGLANDIN-F2-ALPHA, Circulation, 98(17), 1998, pp. 1703-1703
INTERFERON-GAMMA-ATTENUATES CARDIAC-HYPERTROPHY IN A RAT MODEL OF PRESSURE-OVERLOAD
Authors: YANG RH LU HW JIN HK OGASAWARA AK PAONI NF
Citation: Rh. Yang et al., INTERFERON-GAMMA-ATTENUATES CARDIAC-HYPERTROPHY IN A RAT MODEL OF PRESSURE-OVERLOAD, Circulation, 98(17), 1998, pp. 1704-1704
EFFECTS OF EXERCISE TRAINING ON CARDIAC-FUNCTION, GENE-EXPRESSION ANDAPOPTOSIS IN RATS
Authors: YANG R JIN HK II W LU HW RYAN A KO A VANPEBORGH J PAONI NF
Citation: R. Yang et al., EFFECTS OF EXERCISE TRAINING ON CARDIAC-FUNCTION, GENE-EXPRESSION ANDAPOPTOSIS IN RATS, Circulation, 96(8), 1997, pp. 4211-4211
IN-VIVO EFFECTS OF CARDIOTROPHIN-1
Authors: JIN HK YANG RH KELLER GA RYAN A KO A FINKLE D SWANSON TA LI W PENNICA D WOOD WI PAONI NF
Citation: Hk. Jin et al., IN-VIVO EFFECTS OF CARDIOTROPHIN-1, Cytokine, 8(12), 1996, pp. 920-926
PROSTAGLANDIN-F2-ALPHA INDUCES CARDIAC MYOCYTE HYPERTROPHY IN-VITRO AND CARDIAC GROWTH IN-VIVO
Authors: LAI J JIN HK YANG RH WINER J LI W YEN R KING KL ZEIGLER F KO A CHENG J BUNTING S PAONI NF
Citation: J. Lai et al., PROSTAGLANDIN-F2-ALPHA INDUCES CARDIAC MYOCYTE HYPERTROPHY IN-VITRO AND CARDIAC GROWTH IN-VIVO, American journal of physiology. Heart and circulatory physiology, 40(6), 1996, pp. 2197-2208
AN EXPERIMENTAL-MODEL OF INTRACRANIAL HEMORRHAGE DURING THROMBOLYTIC THERAPY WITH T-PA
Authors: PAONI NF STEINMETZ HG GILLETT N REFINO CJ BADILLO JM BUNTING S
Citation: Nf. Paoni et al., AN EXPERIMENTAL-MODEL OF INTRACRANIAL HEMORRHAGE DURING THROMBOLYTIC THERAPY WITH T-PA, Thrombosis and haemostasis, 75(5), 1996, pp. 820-826
SUBSTITUTION OF SERINE OR THREONINE AT POSITION-473 OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR INCREASES ITS STABILITY IN PLASMA
Authors: ALIBHAI M CHOW AM PAONI NF
Citation: M. Alibhai et al., SUBSTITUTION OF SERINE OR THREONINE AT POSITION-473 OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR INCREASES ITS STABILITY IN PLASMA, Thrombosis and haemostasis, 75(1), 1996, pp. 107-112
THE ROLE OF PROSTAGLANDIN-F2-ALPHA IN THE PATHOGENESIS OF CARDIAC-HYPERTROPHY
Authors: JIN HK YANG RH ZEIGLER F KO A PAONI NF
Citation: Hk. Jin et al., THE ROLE OF PROSTAGLANDIN-F2-ALPHA IN THE PATHOGENESIS OF CARDIAC-HYPERTROPHY, Circulation, 94(8), 1996, pp. 3841-3841
BENEFICIAL-EFFECTS OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH-FACTOR-IIN EXPERIMENTAL HEART-FAILURE IN RATS TREATED WITH CHRONIC ACE-INHIBITION
Authors: JIN HK YANG RH GILLETT N CLARK RG KO A PAONI NF
Citation: Hk. Jin et al., BENEFICIAL-EFFECTS OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH-FACTOR-IIN EXPERIMENTAL HEART-FAILURE IN RATS TREATED WITH CHRONIC ACE-INHIBITION, Journal of cardiovascular pharmacology, 26(3), 1995, pp. 420-425
CARDIOTROPHIN-1 - BIOLOGICAL-ACTIVITIES AND BINDING TO THE LEUKEMIA INHIBITORY FACTOR-RECEPTOR GP130 SIGNALING COMPLEX
Authors: PENNICA D SHAW KJ SWANSON TA MOORE MW SHELTON DL ZIONCHECK KA ROSENTHAL A TAGA T PAONI NF WOOD WI
Citation: D. Pennica et al., CARDIOTROPHIN-1 - BIOLOGICAL-ACTIVITIES AND BINDING TO THE LEUKEMIA INHIBITORY FACTOR-RECEPTOR GP130 SIGNALING COMPLEX, The Journal of biological chemistry, 270(18), 1995, pp. 10915-10922
DIVERGENT SIGNALING PATHWAYS MEDIATE THE INDUCTION OF THE ATRIAL-NATRIURETIC-FACTOR GENE DURING CARDIOTROPHIN-1 VERSUS PHENYLEPHRINE MEDIATED CARDIOMYOCYTE HYPERTROPHY
Authors: WOLLERT KC PENNICA D PAONI NF GLEMBOTSKI CC WOOD WI TAGA T KISHIMOTO T CHIEN KR
Citation: Kc. Wollert et al., DIVERGENT SIGNALING PATHWAYS MEDIATE THE INDUCTION OF THE ATRIAL-NATRIURETIC-FACTOR GENE DURING CARDIOTROPHIN-1 VERSUS PHENYLEPHRINE MEDIATED CARDIOMYOCYTE HYPERTROPHY, Circulation, 92(8), 1995, pp. 1144-1144
HEMODYNAMIC-EFFECTS OF CARDIOTROPHIN-1, A NEW CYTOKINE, IN CONSCIOUS RATS
Authors: YANG RH JIN HK PENNICA D WOOD WI PAONI NF
Citation: Rh. Yang et al., HEMODYNAMIC-EFFECTS OF CARDIOTROPHIN-1, A NEW CYTOKINE, IN CONSCIOUS RATS, Circulation, 92(8), 1995, pp. 2720-2720
NEW VARIANT OF HUMAN TISSUE-PLASMINOGEN ACTIVATOR (TPA) WITH ENHANCEDEFFICACY AND LOWER INCIDENCE OF BLEEDING COMPARED WITH RECOMBINANT HUMAN TPA
Authors: BENEDICT CR REFINO CJ KEYT BA PAKALA R PAONI NF THOMAS GR BENNETT WF
Citation: Cr. Benedict et al., NEW VARIANT OF HUMAN TISSUE-PLASMINOGEN ACTIVATOR (TPA) WITH ENHANCEDEFFICACY AND LOWER INCIDENCE OF BLEEDING COMPARED WITH RECOMBINANT HUMAN TPA, Circulation, 92(10), 1995, pp. 3032-3040
ENGINEERING TISSUE-TYPE PLASMINOGEN-ACTIVATOR TO BE RESISTANT TO PLASMA PROTEASE INHIBITORS
Authors: ALIBHAI M CHOW AM NGUYEN HV KEYT BA BENNETT WF PAONI NF
Citation: M. Alibhai et al., ENGINEERING TISSUE-TYPE PLASMINOGEN-ACTIVATOR TO BE RESISTANT TO PLASMA PROTEASE INHIBITORS, Journal of cellular biochemistry, 1994, pp. 150-150
FASTER-ACTING AND MORE POTENT FORM OF TISSUE-PLASMINOGEN ACTIVATOR
Authors: KEYT BA PAONI NF REFINO CJ BERLEAU L NGUYEN H CHOW A LAI J PENA L PATER C OGEZ J ETCHEVERRY T BOTSTEIN D BENNETT WF
Citation: Ba. Keyt et al., FASTER-ACTING AND MORE POTENT FORM OF TISSUE-PLASMINOGEN ACTIVATOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 3670-3674
A SLOW CLEARING, FIBRIN-SPECIFIC, PAI-1 RESISTANT VARIANT OF T-PA (T103N, KHRR-296-299 AAAA)
Authors: PAONI NF KEYT BA REFINO CJ CHOW AM NGUYEN HV BERLEAU LT BADILLO J PENA LC BRADY K WURM FM OGEZ J BENNETT WF
Citation: Nf. Paoni et al., A SLOW CLEARING, FIBRIN-SPECIFIC, PAI-1 RESISTANT VARIANT OF T-PA (T103N, KHRR-296-299 AAAA), Thrombosis and haemostasis, 70(2), 1993, pp. 307-312
A VARIANT OF T-PA (T103N, KHRR-296-299 AAAA) THAT, BY BOLUS, HAS INCREASED POTENCY AND DECREASED SYSTEMIC ACTIVATION OF PLASMINOGEN
Authors: REFINO CJ PAONI NF KEYT BA PATER CS BADILLO JM WURM FM OGEZ J BENNETT WF
Citation: Cj. Refino et al., A VARIANT OF T-PA (T103N, KHRR-296-299 AAAA) THAT, BY BOLUS, HAS INCREASED POTENCY AND DECREASED SYSTEMIC ACTIVATION OF PLASMINOGEN, Thrombosis and haemostasis, 70(2), 1993, pp. 313-319
INCREASING THE FIBRIN SPECIFICITY OF TISSUE-PLASMINOGEN ACTIVATOR
Authors: CHOW AM PENA LC KEYT BA ZOLLER MJ BENNETT WF PAONI NF
Citation: Am. Chow et al., INCREASING THE FIBRIN SPECIFICITY OF TISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 69(6), 1993, pp. 762-762
A VARIANT OF TISSUE-PLASMINOGEN ACTIVATOR (T103N, N117Q, KHRR-296-299AAAA) WITH A DECREASED PLASMA-CLEARANCE RATE, IS SUBSTANTIALLY MORE POTENT THAN ACTIVASE(R) RT-PA IN A RABBIT THROMBOLYSIS MODEL
Authors: REFINO CJ KEYT BA PAONI NF BADILLO JM PATER CS VANPERBORGH J PENA L BERLEAU LT NGUYEN HV BENNETT WF
Citation: Cj. Refino et al., A VARIANT OF TISSUE-PLASMINOGEN ACTIVATOR (T103N, N117Q, KHRR-296-299AAAA) WITH A DECREASED PLASMA-CLEARANCE RATE, IS SUBSTANTIALLY MORE POTENT THAN ACTIVASE(R) RT-PA IN A RABBIT THROMBOLYSIS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 841-841
MAKING TISSUE-TYPE PLASMINOGEN-ACTIVATOR MORE FIBRIN SPECIFIC
Authors: PAONI NF CHOW AM PENA LC KEYT BA ZOLLER MJ BENNETT WF
Citation: Nf. Paoni et al., MAKING TISSUE-TYPE PLASMINOGEN-ACTIVATOR MORE FIBRIN SPECIFIC, Protein engineering, 6(5), 1993, pp. 529-534
Risultati: 1-22 |